Zoetis Inc. is a global leader in animal health, dedicated to supporting the health and well-being of animals through innovative products and services. The company's mission is to empower veterinarians and livestock producers with solutions that enhance animal health and productivity. Zoetis focuses on research and development to create a diverse portfolio of vaccines, medicines, and diagnostic tools for both companion animals and livestock. Its strategy emphasizes sustainability, collaboration with stakeholders, and leveraging advanced technologies to meet the evolving needs of the animal health market, ultimately improving the quality of life for animals and the people who care for them.

ZOETIS INC

Zoetis has recently made headlines after receiving a conditional license from the USDA for its new H5N2 avian influenza vaccine. This development comes in response to ongoing outbreaks of highly pathogenic avian influenza (HPAI) which have affected over 150 million birds in the U.S. since February 2022. The recent culling...

Zoetis Secures Conditional USDA License for Avian Influenza Vaccine Amid Bird Flu Concerns and Rising Egg Prices